RESEARCH TRIANGLE PARK, NC -- (MARKET WIRE) -- 05/15/08 -- According to a recent study byCutting Edge Information, 40% of organizations put their medical affairsdivision at the forefront of developing their thought leaders. The report,"Pharmaceutical Opinion Leader Management: Cultivating Today's InfluentialPhysicians for Tomorrow," examines the ways that pharmaceutical companiesare developing and managing thought leader relationships(http://www.PharmaOpinionLeaders.com).Putting medical affairs at the head of thought leader development helps toensure that all of a company's interactions with influential thoughtleaders closely adhere to the strict OIG guidelines. To encourage fullcompliance, many companies have built firewalls to eliminate any directlinks between the commercial side and the scientific side of the business.In turn, companies have also shifted thought leader development effortsaway from commercial teams and into medical affairs departments.
Companies of all sizes, including pharmaceutical industry's largest mostinfluential organizations, are committed to staying within industryguidelines while interacting with key opinion leaders. "Eachpharmaceutical company is structured differently to best suit its ownneeds. However, they are all interested in staying within the boundariesoutlined by the regulatory bodies," says Elio Evangelista, research teamleader at Cutting Edge Information.
"Pharmaceutical Opinion Leader Management: Cultivating Today's InfluentialPhysicians for Tomorrow" is a study of 41 pharmaceutical, biotechnology andmedical device companies' thought leader management structures, resources,processes and activities. The report includes detailed segmentation andfunding data collected from top companies, such as Pfizer, Bristol-MyersSquibb, Schering-Plough and Novartis.
Download a free summary of "Pharmaceutical Opinion Leader Management:Cultivating Today's Influential Physicians for Tomorrow" or purchase thereport at:http://www.cuttingedgeinfo.com/pharmaopinionleaders/index.htm#body
CONTACT:
Elio Evangelista
(919) 433-0214
Email Contact